ZyVersa Therapeutics, Inc. (ZVSA) Stock Forecast
ZVSA analyst forecast
as of October 21, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $20.00 average of analyst targets
- Upside to target
- +1,999,900.0% from the latest close
- Next earnings
- —
- 52-week range
- $0.00 – $0.30
ZVSA analyst ratings
1 analystsNumber of analysts at each rating.
ZVSA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ZVSA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ZVSA beat in 2 of 9.
What analysts expect from ZVSA
1 analysts cover ZyVersa Therapeutics; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $20.00, 1,999,900.0% above the latest close of $0.00. ZyVersa Therapeutics beat the EPS estimate in 2 of the last 9 quarters.
Related: ZVSA income statement, ZVSA key metrics, ZVSA chart. See the ZVSA stock overview for the latest quote and news.
ZVSA forecast FAQ
What is ZyVersa Therapeutics's price target?
The average analyst price target for ZyVersa Therapeutics is $20.00, 1,999,900.0% above the latest close of $0.00.
Is ZyVersa Therapeutics a buy, hold or sell?
Of 1 analysts covering ZyVersa Therapeutics, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
Does ZyVersa Therapeutics usually beat earnings estimates?
ZyVersa Therapeutics reported EPS at or above the analyst estimate in 2 of the last 9 quarters.